Urofollitropin
 |
This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (December 2009) |
| Systematic (IUPAC) name | |
|---|---|
| Human follicle stimulating hormone | |
| Clinical data | |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 146479-72-3  |
| ATC code | G03GA04 |
| PubChem | CID 62819 |
| DrugBank | BTD00104 |
| UNII | W9BB98U6HP  |
| KEGG | D06400 |
| ChEMBL | CHEMBL1201520 |
| Chemical data | |
| Formula | C975H1513N267O304S26 |
| Mol. mass | 22672.9 g/mol |
 (what is this?) (verify) |
|
Urofollitropin is a purified form of follicle-stimulating hormone that is manufactured by extraction from human urine and then purified to remove various proteins and other substances. FSH is important in the development of follicles (eggs) produced by the ovaries. Given by subcutaneous injection, it is used in combination with human chorionic gonadotropin (hCG) to assist in ovulation and fertility. It is also used with in vitro fertilization methods. The dosage is adjusted to each individual's response.
Its side effects include breast tenderness, mild diarrhea, nausea, or vomiting, shortness of breath, constipation and hot flashes, increased risk of uterine carcinoma and birth defects if you are pregnant while taking the drug.
[edit] Brand Names / Manufacturers
- Bravelle - Ferring Pharmaceuticals Switzerland
http://www.ferringfertility.com/medications/bravelle/
- Fertinex Scherring-Plough Kenilworth NJ USA
http://www.follistim.com/consumer/index.asp
- Fostimon non US Institut Biochemique SA - Switzerland
http://www.ibsa.ch/welcome-intl/products-fertility-fostimon-intl.htm
- Fostine - CIMS India
http://www.mims.com/India/drug/info/FOSTINE/FOSTINE%20vial
|
|||||||||||||||||||||
 |
This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
